Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

July 31, 1999

Study Completion Date

May 31, 2003

Conditions
Ovarian Cancer
Interventions
DRUG

bryostatin 1

Trial Locations (4)

M20 4BX

Christie Hospital N.H.S. Trust, Manchester

0X3 9DU

Oxford Radcliffe Hospital, Oxford

S1O 2SJ

Weston Park Hospital, Sheffield

G4 0SF

Royal Infirmary, Glasgow

All Listed Sponsors
lead

University of Glasgow

OTHER

NCT00004008 - Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer | Biotech Hunter | Biotech Hunter